Results - Announcements
Syngene International Ltd share price gained 1.74% to Rs 366.0 after the company's net profit tanked by 457.78% to Rs 32.2 crore, while revenue from operations increased 13.14% to Rs 832.7 crore in Q3FY26 over Q2FY26.
The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 41159.89 crore, easing 4.19%. It has eased by 0.93% over last one week and eased lower by 2.37% in last one month while the market capitalization of Syngene International Ltd has slipped by 2.74% and 8.24% in the same period respectively.
Profit before tax (PBT) of Syngene International Ltd stood at Rs 47.0 crore in Q3 FY26, tumbling by 44.84% year-on-year, and crashing by 344.79% quarter-on-quarter. EBITDA came in at Rs 119 crore, plunging by 35.14% YoY and rallying 82.29% sequentially.
Total expenses saw a slight increase of 5.23% to Rs 797.0 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 203.0 crore, going up by 13.92% YoY, while employee benefits expense was at Rs 272.7 crore, ticking higher by 0.59% YoY.
For the TTM ended FY26, revenue from operations tick up 2.64% to Rs 3738.7 crore, while net profit tumbled by 36.17% to Rs 316.7 crore, compared to previous TTM. EBITDA surged by 98930% to Rs 847.8 crore, and PBT collapsed by 37.73% to Rs 410.9 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 915.2 crore in FY26, as against Rs 1167.6 crore in FY25.
Syngene International Ltd crashed 44.57% in last one year, underperforming the benchmark BSE Sensex which has reduced by 13.19% during the same period.